LUNGOV

Serial Number 79349653
Registration 7204078
700

Registration Progress

Application Filed
Jun 21, 2022
Under Examination
Approved for Publication
Aug 15, 2023
Published for Opposition
Aug 15, 2023
Registered
Oct 31, 2023

Trademark Image

LUNGOV

Basic Information

Serial Number
79349653
Registration Number
7204078
Filing Date
June 21, 2022
Registration Date
October 31, 2023
Published for Opposition
August 15, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 31, 2023
Registration
Registered
Classes
005

Rights Holder

XENOTHERA

34
Address
21 rue de la Noue Bras de Fer
F-44200 Nantes
FR

Ownership History

XENOTHERA

Original Applicant
34
FR

XENOTHERA

Owner at Publication
34
FR

XENOTHERA

Original Registrant
34
FR

Legal Representation

Attorney
Ronald M. Kachmarik

USPTO Deadlines

Next Deadline
1365 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20231031)
Due Date
October 31, 2029
Grace Period Ends
April 30, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description Documents
Jun 19, 2025 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Feb 26, 2024 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Feb 5, 2024 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Feb 5, 2024 FIMP P FINAL DISPOSITION PROCESSED Loading...
Jan 31, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Oct 31, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Oct 31, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 21, 2023 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Aug 15, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 15, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 2, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Aug 2, 2023 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Jul 26, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 12, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 26, 2023 RFNT P REFUSAL PROCESSED BY IB Loading...
Jun 22, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 21, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 21, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 6, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jun 6, 2023 RFRR P REFUSAL PROCESSED BY MPU Loading...
Apr 10, 2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Apr 9, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 1, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 20, 2022 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Sep 16, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 15, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical products, namely, pharmaceuticals products for use in human or veterinary medicine for the prevention and treatment of infectious diseases; chemical preparations for medical or pharmaceutical use, namely, for the prevention and treatment of infectious diseases; diagnostic products for medical use, namely, diagnostic reagents and diagnostic biomarker reagents for use in human or veterinary medicine; chemical reagents for medical or veterinary use; monoclonal antibodies for medical and pharmaceutical use; pharmaceutical products and preparations for cell therapy, for the prevention and treatment of infectious diseases; biological preparations for use in human or veterinary medicine, or for pharmaceutical use for prevention and treatment of infectious diseases; microorganism cultures for use in human or veterinary medicine, or for pharmaceutical use; cell preparations for use in human or veterinary medicine, or for pharmaceutical use, in particular for gene therapy and cell therapy

Classification

International Classes
005